Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Citi downgrades Drax to 'neutral' from 'buy'

(Sharecast News) - Citi downgraded Drax on Thursday to 'neutral' from 'buy' as it said the shares were already discounting much of the probability-weighted upside, but lifted the price target to 923p from 850p. The bank noted that Drax has been a standout performer in an arguably fully-valued sector, with the shares up about 25% over the past three months.

"Our previous upgrade was underpinned by the optionality value around potential AI/DC development embedded in Drax's 'old-world' assets, which we captured through a probability-weighted approach," it said. "We now see the shares fairly pricing in that optionality and see a growing expectation of delivery from Drax to support current valuation."

In the meantime, Citi said Drax has shifted focus towards FlexGen, which the bank thinks can benefit from structural changes in the UK energy system.

"Pellets remain more uncertain long-term, however strong medium-term offtake visibility should alleviate investor concerns in that division for now," Citi said.

At 1310 GMT, the shares were down 1.8% at 854p.

Share this article

Related Sharecast Articles

Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.
Bloomsbury shares spark on 2027 profit outlook
(Sharecast News) - Shares in Bloomsbury Publishing shot higher on Thursday after it said profit for the year ending 28 February 2027 was set to be "materially ahead" of market expectations as Sarah J. Maas will publish her next two novels within the next year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.